Drug Profile
ELB 245
Alternative Names: ELB245Latest Information Update: 20 Jul 2010
Price :
$50
*
At a glance
- Originator elbion NV
- Class Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 20 Jul 2010 Discontinued - Phase-II for Overactive bladder in Germany (unspecified route)
- 20 Jul 2010 Discontinued - Phase-II for Overactive bladder in Poland (unspecified route)
- 20 Jul 2010 Discontinued - Phase-II for Overactive bladder in Sweden (unspecified route)